During the past decade, Kennedy Krieger Institute conducted 83 clinical trials. In the 10-year time frame, 83 clinical trials started and 37 clinical trials were completed, i.e. on average, 44.6% percent of trials that started reached the finish line to date. In the past 5 years, 36 clinical trials started and 28 clinical trials were completed. i.e. 77.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kennedy Krieger Institute" #1 sponsor was "Hugo W. Moser Research Institute at Kennedy Krieger, Inc." with 36 trials, followed by "Sunovion" with 6 trials sponsored, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 4 trials sponsored, "Sarepta Therapeutics, Inc." with 4 trials sponsored and "Seaside Therapeutics, Inc." with 4 trials sponsored. Other sponsors include 76 different institutions and companies that sponsored additional 59 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kennedy Krieger Institute" #1 collaborator was "Hugo W. Moser Research Institute at Kennedy Krieger, Inc." with 8 trials as a collaborator, "Johns Hopkins University" with 7 trials as a collaborator, "National Institute of Mental Health (NIMH)" with 5 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 4 trials as a collaborator and "National Institutes of Health (NIH)" with 4 trials as a collaborator. Other collaborators include 122 different institutions and companies that were collaborators in the rest 103 trials.

According to Clinical.Site data, the most researched conditions in "Kennedy Krieger Institute" are "Duchenne Muscular Dystrophy" (15 trials), "Autism Spectrum Disorder" (14 trials), "Autism" (7 trials), "Fragile X Syndrome" (7 trials) and "Spinal Cord Injury" (5 trials). Many other conditions were trialed in "Kennedy Krieger Institute" in a lesser frequency.

Most popular intervention types in "Kennedy Krieger Institute" are "Drug" (71 trials), "Behavioral" (28 trials), "Device" (11 trials), "Other" (10 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (28 trials), "HT-100" (3 trials), "Losmapimod" (3 trials), "SPD489" (3 trials) and "Cannabidiol" (2 trials). Other intervention names were less common.

The vast majority of trials in "Kennedy Krieger Institute" are 110 trials for "All" genders and 25 trials for "Male" genders.

Currently, there are NaN active trials in "Kennedy Krieger Institute". undefined are not yet recruiting, 27 are recruiting, 9 are Active, not recruiting, and 4 are Enrolling by invitation. In total, there were 69 completed trials in Kennedy Krieger Institute, undefined suspended trials, and 21 terminated clinical trials to date.

Out of the total trials that were conducted in Kennedy Krieger Institute, 10 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 36 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 33 trials that are defined as “Not Applicable".

Kennedy Krieger Institute has several departments that took part in Clinical trials: "Kennedy Krieger Institute - Clinical Trials Unit" - 2 trials, "Rebecca Martin, OTR/L, OTD, CPAM" - 2 trials